These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22396598)

  • 1. Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug.
    da Cruz FP; Martin C; Buchholz K; Lafuente-Monasterio MJ; Rodrigues T; Sönnichsen B; Moreira R; Gamo FJ; Marti M; Mota MM; Hannus M; Prudêncio M
    J Infect Dis; 2012 Apr; 205(8):1278-86. PubMed ID: 22396598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor.
    Nam TG; McNamara CW; Bopp S; Dharia NV; Meister S; Bonamy GM; Plouffe DM; Kato N; McCormack S; Bursulaya B; Ke H; Vaidya AB; Schultz PG; Winzeler EA
    ACS Chem Biol; 2011 Nov; 6(11):1214-22. PubMed ID: 21866942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone-3-diarylethers: a new class of antimalarial drug.
    Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
    Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.
    Zeeman AM; van Amsterdam SM; McNamara CW; Voorberg-van der Wel A; Klooster EJ; van den Berg A; Remarque EJ; Plouffe DM; van Gemert GJ; Luty A; Sauerwein R; Gagaring K; Borboa R; Chen Z; Kuhen K; Glynne RJ; Chatterjee AK; Nagle A; Roland J; Winzeler EA; Leroy D; Campo B; Diagana TT; Yeung BK; Thomas AW; Kocken CH
    Antimicrob Agents Chemother; 2014; 58(3):1586-95. PubMed ID: 24366744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pre-emptive strike against malaria's stealthy hepatic forms.
    Mazier D; Rénia L; Snounou G
    Nat Rev Drug Discov; 2009 Nov; 8(11):854-64. PubMed ID: 19876040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Decoquinate Solid Dispersion by Hot-Melt Extrusion as an Oral Dosage Form Targeting Liver-Stage
    Wang H; Fan Y; Qin L; Cheng Z; Chen X; Zeng S; Liang S; Tong Y; Tao Z; Liu Y; Liu X; Ning X; Chen P; Zhao S; Chen X
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0221821. PubMed ID: 35658489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.
    March S; Ng S; Velmurugan S; Galstian A; Shan J; Logan DJ; Carpenter AE; Thomas D; Sim BK; Mota MM; Hoffman SL; Bhatia SN
    Cell Host Microbe; 2013 Jul; 14(1):104-15. PubMed ID: 23870318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria.
    Zeng S; Wang H; Tao L; Ning X; Fan Y; Zhao S; Qin L; Chen X
    Malar J; 2022 Jan; 21(1):24. PubMed ID: 35073922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.
    Chang ZW; Malleret B; Russell B; Rénia L; Claser C
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6859-6866. PubMed ID: 27600050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying malaria parasite's heme detoxification system for screening potential antimalarial drugs.
    Sahal D; Kannan R; Chauhan VS
    Anal Biochem; 2003 Jan; 312(2):258-60. PubMed ID: 12531215
    [No Abstract]   [Full Text] [Related]  

  • 14. Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes.
    Goodman CD; Siregar JE; Mollard V; Vega-Rodríguez J; Syafruddin D; Matsuoka H; Matsuzaki M; Toyama T; Sturm A; Cozijnsen A; Jacobs-Lorena M; Kita K; Marzuki S; McFadden GI
    Science; 2016 Apr; 352(6283):349-53. PubMed ID: 27081071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum(ii)-chloroquine complexes are antimalarial agents against blood and liver stages by impairing mitochondrial function.
    Macedo TS; Villarreal W; Couto CC; Moreira DRM; Navarro M; Machado M; Prudêncio M; Batista AA; Soares MBP
    Metallomics; 2017 Nov; 9(11):1548-1561. PubMed ID: 28960224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models for human malaria: targeting the liver stage.
    Valenciano AL; Gomez-Lorenzo MG; Vega-Rodríguez J; Adams JH; Roth A
    Trends Parasitol; 2022 Sep; 38(9):758-774. PubMed ID: 35780012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting Plasmodium cytochrome bc1: a complex issue.
    Barton V; Fisher N; Biagini GA; Ward SA; O'Neill PM
    Curr Opin Chem Biol; 2010 Aug; 14(4):440-6. PubMed ID: 20570550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroquinazolinone inhibitors of proliferation of blood and liver stage malaria parasites.
    Derbyshire ER; Min J; Guiguemde WA; Clark JA; Connelly MC; Magalhães AD; Guy RK; Clardy J
    Antimicrob Agents Chemother; 2014; 58(3):1516-22. PubMed ID: 24366746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.